Silk Road Medical Inc. (SILK) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts SILK Hot Sheet
Join SI Premium – FREE
Silk Road Medical Inc. (NASDAQ: SILK) reported Q2 EPS of ($0.42), $0.05 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $51.24 million versus the consensus estimate of $49.72 million.
For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intrepid Potash (IPI) PT Lowered to $41 at Freedom Broker
- Fox Corporation (FOX) Tops Q1 EPS by 48c
- Bitmine reports 6.06M ETH holdings, total assets of $14.5B
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
